Forced expression of stabilized c-Fos in dendritic cells reduces cytokine production and immune responses in vivo

Biochemical and Biophysical Research Communications

Volumn 423, Issue 2, 2012, Pages 247-252

  Yoshida, Ryoko ^a,b   Suzuki, Mayu ^a,b   Sakaguchi, Ryota ^a,b   Hasegawa, Eiichi ^a,b   Kimura, Akihiro ^a,b   Shichita, Takashi ^a,b   Sekiya, Takashi ^a,b   Shiraishi, Hiroshi ^c   Shimoda, Kouji ^a   Yoshimura, Akihiko ^a,b  

^a KEIO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

C Fos; Cytokine; Dendritic cell; EAE; Immune response

Indexed keywords

GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; PROTEIN C FOS; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TRANSGENIC MOUSE; WILD TYPE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD11C; CYTOKINES; DENDRITIC CELLS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-FOS; TRANSGENES;

MUS; MUS MUSCULUS;

EID: 84862889816     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.097     Document Type: Article

References (24)

1. Takeda K., Akira S. TLR signaling pathways. Semin. Immunol. 2004, 16:3-9.
2. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
3. Sugiyama Y., Kakoi K., Kimura A., Takada I., Kashiwagi I., Wakabayashi Y., Morita R., Nomura M., Yoshimura A. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways. Int. Immunol. 2012, 24:253-265.
4. Shiraishi H., Yoshida H., Saeki K., Miura Y., Watanabe S., Ishizaki T., Hashimoto M., Takaesu G., Kobayashi T., Yoshimura A. Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells. Int. Immunol. 2008, 20:1219-1229.
5. Jutel M., Watanabe T., Akdis M., Blaser K., Akdis C.A. Immune regulation by histamine. Curr. Opin. immunol. 2002, 14:735-740.
6. La Sala A., Ferrari D., Corinti S., Cavani A., Di Virgilio F., Girolomoni G. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J. Immunol. 2001, 166:1611-1617.
7. Pozo D. VIP- and PACAP-mediated immunomodulation as prospective therapeutic tools. Trends Mol. Med. 2003, 9:211-217.
8. Yasukawa H., Ohishi M., Mori H., Murakami M., Chinen T., Aki D., Hanada T., Takeda K., Akira S., Hoshijima M., Hirano T., Chien K.R., Yoshimura A. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 2003, 4:551-556.
9. Koga K., Takaesu G., Yoshida R., Nakaya M., Kobayashi T., Kinjyo I., Yoshimura A. Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity 2009, 30:372-383.
10. Ray N., Kuwahara M., Takada Y., Maruyama K., Kawaguchi T., Tsubone H., Ishikawa H., Matsuo K. C-Fos suppresses systemic inflammatory response to endotoxin. Int. Immunol. 2006, 18:671-677.
11. S. Jung, D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, E.G. Pamer, D.R. Littman, R.A. Lang, In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens, Immunity. 17 (2002) 211-220.
12. Matsumura Y., Kobayashi T., Ichiyama K., Yoshida R., Hashimoto M., Takimoto T., Tanaka K., Chinen T., Shichita T., Wyss-Coray T., Sato K., Yoshimura A. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J. Immunol. 2007, 179:2170-2179.
13. Chinen T., Komai K., Muto G., Morita R., Inoue N., Yoshida H., Sekiya T., Yoshida R., Nakamura K., Takayanagi R., Yoshimura A. Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance. Nat. Commun. 2011, 2:190.
14. Ichiyama K., Sekiya T., Inoue N., Tamiya T., Kashiwagi I., Kimura A., Morita R., Muto G., Shichita T., Takahashi R., Yoshimura A. Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-beta is mediated by suppression of eomesodermin. Immunity 2011, 34:741-754.
15. Yoshida H., Kimura A., Fukaya T., Sekiya T., Morita R., Shichita T., Inoue H., Yoshimura A. Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation. Biochem. Biophys. Res. Commun. 2012, 418:234-240.
16. Sekiya T., Kashiwagi I., Inoue N., Morita R., Hori S., Waldmann H., Rudensky A.Y., Ichinose H., Metzger D., Chambon P., Yoshimura A. The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat. Commun. 2011, 2:269.
17. Takahashi R., Nishimoto S., Muto G., Sekiya T., Tamiya T., Kimura A., Morita R., Asakawa M., Chinen T., Yoshimura A. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-gamma and IL-17A production. J. Exp. Med. 2011, 208:2055-2067.
18. Hume D.A. Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity. J. Leu. Biol. 2011, 89:525-538.
19. Mosenden R., Tasken K. Cyclic AMP-mediated immune regulation-overview of mechanisms of action in T cells. Cell. Signal. 2011, 23:1009-1016.
20. Harzenetter M.D., Novotny A.R., Gais P., Molina C.A., Altmayr F., Holzmann B. Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER. J. Immunol. 2007, 179:607-615.
21. E.A. Wall, J.R. Zavzavadjian, M.S. Chang, B. Randhawa, X. Zhu, R.C. Hsueh, J. Liu, A. Driver, X.R. Bao, P.C. Sternweis, M.I. Simon, I.D. Fraser, Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105, Sci. Signal. 2 (2009) ra28.
22. Bopp T., Becker C., Klein M., Klein-Hessling S., Palmetshofer A., Serfling E., Heib V., Becker M., Kubach J., Schmitt S., Stoll S., Schild H., Staege M.S., Stassen M., Jonuleit H., Schmitt E. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 2007, 204:1303-1310.
23. Jain J., Miner Z., Rao A. Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J. Immunol. 1993, 151:837-848.
24. Yao C., Sakata D., Esaki Y., Li Y., Matsuoka T., Kuroiwa K., Sugimoto Y., Narumiya S. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 2009, 15:633-640.